The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDavictus Regulatory News (DVT)

Share Price Information for Davictus (DVT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.25
Bid: 3.50
Ask: 5.00
Change: 0.00 (0.00%)
Spread: 1.50 (42.857%)
Open: 4.25
High: 4.25
Low: 4.25
Prev. Close: 4.25
DVT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Equity Fundraise

21 Jun 2021 09:00

RNS Number : 5138C
daVictus plc
21 June 2021
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED THEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLYOR INDIRECTLY IN OR INTO AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF ANY RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES IN DAVICTUS PLC OR ANY OTHER ENTITY IN ANY SUCH JURISDICTION.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION (EU NO. 596/2014) AS IT FORMS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("UK MAR").

 

21 June 2021

 

daVictus plc

("daVictus")

 

EQUITY FUNDRAISE

 

Davictus Plc ("Davictus" or the "Company") announces it has completed (subject to certain conditions) an equity fundraise of £36,000 (gross) (the "Fundraise") through the issue of 1,200,000 ordinary shares of no par value (the "Fundraise Shares") at a price of 3.0 pence per ordinary share.

 

The Fundraise has been undertaken by way of a placing of new ordinary shares ("Placing") of no par value ("Ordinary Shares") in the share capital of the Company and was arranged by Optiva Securities Limited ("Optiva") with its clients. The Fundraise is to provide additional working capital for the Company.

 

The Fundraise has been undertaken by means of the Placing pursuant to which, the Company will issue 1,200,000 ordinary shares at a price of 3.0p per new ordinary share, based on closing price of the ordinary shares on 18 June 2021 (being the last practicable dealing date prior to the pricing of this transaction).

 

Following admission of the Fundraising Shares to the standard listing segment of the Official List of the Financial Conduct Authority ("FCA") and to trading on the Main Market of the London Stock Exchange, which is expected to occur at 8.00 am on the 29th June 2021, the total number of Ordinary Shares in the Company will be 13,350,000. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

For more information please visit the Company's website at www.davictus.co.uk.

 

End

 

For further information, please contact:

 

Investor Relations Team

ir@davictus.co.uk

 

Jeremy King

Optiva Securities Limited

Tel: +44(0)203 137 1904

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEPPUBWQUPGUCG
12
Date   Source Headline
7th Feb 20247:00 amRNSChange of Adviser
4th Sep 20239:39 amRNSINTERIM FINANCIAL STATEMENTS ENDED 30 JUNE 2023
9th Aug 20239:28 amRNSDavictus PLC: Result of AGM year 2023
23rd Jun 202310:22 amRNSNotice of AGM
27th Apr 20234:44 pmRNSAUDITED ANNUAL RESULTS TO 31 DECEMBER 2022
27th Sep 202210:21 amRNSResult of AGM 2022
15th Sep 20227:00 amRNSINTERIM FINANCIAL STATEMENTS ENDED 30 JUNE 2022
5th Sep 20221:52 pmRNSNotice of AGM year 2022
13th May 202210:57 amRNSAnnual Financial Report ended 31 December 2021
21st Feb 20228:00 amRNSAppointment of auditor
29th Oct 20219:00 amRNSAgreement
18th Oct 20219:11 amRNSHalf-year Report ended 30 June 2021
23rd Sep 20219:28 amRNSResult of AGM
16th Aug 202110:53 amRNSNotice of AGM 2021
29th Jul 202111:54 amRNSFINAL RESULTS ENDED 31 DECEMBER 2020
29th Jun 20218:36 amRNSTEMPORARY SUSPENSION OF TRADING
29th Jun 20217:30 amRNSSuspension - daVictus Plc
21st Jun 20219:00 amRNSEquity Fundraise
30th Sep 20209:31 amRNSResult of AGM
30th Sep 20208:00 amRNSDavictus PLC: Half-year Report
7th Sep 20201:35 pmRNSNotice of AGM
19th Jun 202010:24 amRNSAnnual Financial Report
26th Mar 20208:00 amRNSAppointment of Franchisee
10th Mar 20207:00 amRNSRE-ADMISSION TO LISTING AND TO TRADING ON THE LSE
5th Mar 20203:31 pmRNSSUPPLEMENTARY PROSPECTUS PUBLICATION
21st Feb 20202:15 pmRNSPublication of a Prospectus
4th Sep 20199:00 amRNSHalf-year Report
1st Aug 20199:24 amRNSResult of AGM
10th Jul 20193:02 pmRNSNotice of AGM
29th Apr 201910:38 amRNSAnnual Financial Report
25th Mar 20198:55 amRNSNew directorship notification Listing Rule 9.6.14
20th Feb 20197:30 amRNSSuspension of Ordinary Shares
17th Dec 20187:00 amRNSChange of Registered Office
22nd Nov 20188:40 amRNSResult of AGM
22nd Oct 20187:00 amRNSNotice of AGM
24th Aug 20188:00 amRNSHalf-year Report
24th Apr 20189:00 amRNSAnnual Financial Report 2018
29th Mar 20188:00 amRNSChange of Registered Office
5th Sep 20177:41 amRNSHalf-year Report as of June 2017
13th Jul 20179:48 amRNSResult of AGM
14th Jun 20172:14 pmRNSNotice of AGM
7th Jun 201712:24 pmRNSNotice of AGM
11th May 20179:23 amRNSNotice of AGM
27th Apr 20177:00 amRNSAnnual Financial Report
21st Sep 20161:34 pmRNSHalf-year Report
8th Jul 201610:35 amRNSResult of AGM
10th Jun 20164:00 pmRNSNotice of AGM
29th Apr 20167:00 amRNSFinal Results and Annual Financial Report
13th Apr 20164:40 pmRNSSecond Price Monitoring Extn
13th Apr 20164:35 pmRNSPrice Monitoring Extension
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.